Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer?
Researchers determined the prognostic ability of three NOTCH1 gene variants by incorporating them into two... read more
February 24, 2022
Category: Oncotarget
Trending With Impact: New Pre-Transplant AML Treatment Combinations
Researchers aimed to improve acute myeloid leukemia (AML) patient outcomes after allo-HSCT with new pre-transplant... read more
February 17, 2022
Iron Chelators in Cancer Treatment
In a review paper published in Oncotarget in 2021, researchers discuss the impact of iron... read more
February 10, 2022
Trending With Impact: What Causes Chemo Brain?
Researchers investigated potential therapeutic culprits of “chemo brain” in a trending new paper published by... read more
January 28, 2022
Prognostic Markers Identified in Ultra-Rare Adrenal Cancer
Researchers demonstrated the overexpression of the protein APOBEC3B in adrenocortical carcinoma. They also identified the... read more
January 26, 2022
Oncotarget’s Top 10 Most-Viewed Papers in 2021
Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021.—#10: Metformin and... read more
January 21, 2022
Gene Mutations and Neoantigens in Head and Neck Tumors
The aim of this exploratory study was to characterize the genomic and neoantigen changes in... read more
January 13, 2022
Open-Access Oncotarget Shifts to Continuous Publishing
As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous... read more
January 6, 2022
Can Purified Cholera Stop Obesity?
In this 2019 study, researchers investigated the effects of purified elements of cholera toxin in... read more
December 31, 2021
New Study: Biomarkers Linked to the Progression of Endometrial Cancer
Researchers conducted a study to identify differentially regulated signaling pathways and genes related to endometrial... read more
December 22, 2021